Vivani Medical (VANI) Assets Average (2018 - 2026)
Vivani Medical (VANI) posted Assets Average of $42.0 million for Q2 2026, up 2.75% on a QoQ basis from $40.9 million in Q1 2026, and up 30.51% year-over-year from $32.2 million in Q2 2025.
Analysis
Vivani Medical (VANI) Assets Average (2018 - 2026) Analysis & Trends
Vivani Medical has reported Assets Average for 9 years, with the latest figure at $42.0 million in Q2 2026.
- On a quarterly basis, Assets Average rose 30.51% year-over-year to $42.0 million in Q2 2026; TTM through Jun 2026 was $42.0 million, a 30.51% increase from a year earlier, with the FY2025 full-year figure at $40.5 million, down 7.33% from the prior year.
- Assets Average was $42.0 million for Q2 2026 at Vivani Medical, up from $40.9 million in the prior quarter.
- The five-year high for Assets Average was $67.1 million in Q2 2022, with the low at $27.0 million in Q3 2025.
- Average Assets Average over 5 years is $45.9 million, with a median of $46.7 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2025: Assets Average surged 126.93% in 2022, then plunged 40.79% in 2025.
- Over 5 years, Assets Average stood at $54.1 million in 2022, then dropped by 8.35% to $49.6 million in 2023, then slipped by 14.79% to $42.2 million in 2024, then fell by 23.7% to $32.2 million in 2025, then jumped by 30.34% to $42.0 million in 2026.
- The last three Assets Average figures came in at $42.0 million (Q2 2026), $40.9 million (Q1 2026), and $32.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 200.98 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 135.79 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 129.24 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 120.28 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 204.57 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 149.95 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 3.29 Bn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 7.61 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 6.97 Bn |
| 10 | Vivani Medical | 109.30 Mn | 89.40 Mn | - | 42.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.00 Mn |
| Mar 31, 2026 | 40.87 Mn |
| Dec 31, 2025 | 32.22 Mn |
| Sep 30, 2025 | 26.98 Mn |
| Jun 30, 2025 | 32.18 Mn |
| Mar 31, 2025 | 38.51 Mn |
| Dec 31, 2024 | 42.23 Mn |
| Sep 30, 2024 | 45.56 Mn |
| Jun 30, 2024 | 51.01 Mn |
| Mar 31, 2024 | 49.79 Mn |
| Dec 31, 2023 | 49.56 Mn |
| Sep 30, 2023 | 56.46 Mn |
| Jun 30, 2023 | 52.09 Mn |
| Mar 31, 2023 | 47.86 Mn |
| Dec 31, 2022 | 54.08 Mn |
| Sep 30, 2022 | 61.34 Mn |
| Jun 30, 2022 | 67.09 Mn |
| Mar 31, 2022 | 37.00 Mn |
| Dec 31, 2021 | 39.54 Mn |
| Sep 30, 2021 | 74.77 Mn |